Daniel Regelein's disclosure footprint centers on a narrowly scoped product, dr_blob, with observed vulnerabilities concentrated in cross-site scripting and related input-handling issues common to web-facing applications. Treat this as a compact vendor profile; live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Daniel Regelein over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2009-4391MEDIUM Cross-site scripting (XSS) vulnerability in the File list (dr_blob) extension 2.1.1 for TYPO3 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors | Dec 22, 2009 | 4.3 | 14 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Daniel Regelein.
Media articles that mention a CVE ID that affects a product developed by Daniel Regelein — matched by CVE ID, not by vendor name.